Business Context and Reporting Period
Company: The Allstate Corporation
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Overview: Allstate is a leading property and casualty insurer. The period was marked by significant strategic divestitures, including the sale of the Employer Voluntary Benefits (EVB) business and the closing of the Group Health business sale. The company reported strong underwriting performance in its core Auto and Homeowners lines, offset by elevated catastrophe losses.
Key Financial Metrics
| Metric ($ millions) | Q2 2025 | Q2 2024 | 6M 2025 | 6M 2024 |
|---|---|---|---|---|
| Total Revenues | 16,633 | 15,714 | 33,085 | 30,973 |
| Net Income Applicable to Common Shareholders | 2,079 | 301 | 2,645 | 1,490 |
| Earnings Per Share (Diluted) | $7.76 | $1.13 | $9.85 | $5.58 |
| Property-Liability Underwriting Income | 1,280 | (145) | 1,640 | 753 |
| Combined Ratio (Property-Liability) | 91.1% | 101.1% | 94.2% | 97.1% |
| Net Investment Income | 754 | 712 | 1,608 | 1,476 |
| Total Assets | 115,894 | — | — | — |
| Total Investments | 77,437 | — | — | — |
| Shareholders' Equity | 24,019 | — | — | — |
| Debt | 8,087 | — | — | — |
Note: Balance sheet figures are as of June 30, 2025. Prior year balance sheet data is not provided in the text.
Material Changes vs. Prior Period
- Profitability Surge: Net income applicable to common shareholders increased 591% in Q2 2025 compared to Q2 2024. This was driven by a $890 million pre-tax gain on the sale of the EVB business and improved underwriting results.
- Underwriting Improvement: Property-Liability underwriting income turned from a $145 million loss in Q2 2024 to a $1.28 billion profit in Q2 2025. The combined ratio improved to 91.1% from 101.1%.
- Catastrophe Losses: Catastrophe losses were $1.99 billion in Q2 2025 (down from $2.12 billion in Q2 2024) but increased significantly year-to-date to $4.19 billion (vs. $2.85 billion in 2024), primarily due to California wildfires and wind/hail events.
- Segment Performance:
- Allstate Protection: Underwriting income of $1.28 billion in Q2 2025 vs. a $142 million loss in Q2 2024.
- Allstate Health and Benefits: Adjusted net income dropped to $4 million in Q2 2025 from $58 million in Q2 2024, largely due to the EVB sale and increased benefit utilization in remaining health lines.
- Protection Services: Adjusted net income grew to $60 million in Q2 2025 from $55 million in Q2 2024.
- Investment Portfolio: Total investments grew to $77.44 billion from $72.61 billion at year-end 2024. Unrealized net capital gains on fixed income securities improved significantly to $52 million (from a loss of $869 million at Dec 31, 2024).
Guidance, Outlook, and Risks
- Divestitures: The company closed the sale of its EVB business for $1.9 billion in cash (net) in Q2 2025. The sale of the Group Health business closed on July 1, 2025, with an expected gain of approximately $500 million to be recorded in Q3 2025.
- Capital Actions: The company repurchased $445 million of common stock in the first six months of 2025. A $1.50 billion share repurchase program authorized in February 2025 has $1.06 billion remaining. Dividends paid were $509 million (common) and $59 million (preferred) for the six-month period.
- Macro Risks: Management highlighted risks from new U.S. tariffs announced in April 2025, which could increase vehicle and building material costs, thereby driving up claims costs. Other risks include inflation, labor shortages, and geopolitical conflicts.
- Reserving Uncertainty: The company noted that inflation and complex repair trends make historical loss development less predictive, creating potential reserve variability.
- Legal Proceedings: The company is defending various class actions regarding depreciation practices in homeowner claims, total loss vehicle valuations, and uninsured/underinsured motorist stacking. The estimated aggregate range of reasonably possible loss in excess of accruals is $0 to $72 million.
Investor Verification Checklist
- Gain on Sale Sustainability: Verify the impact of the $890 million EVB sale gain on net income; this is a non-recurring item.
- Catastrophe Exposure: Review the $4.19 billion YTD catastrophe losses and the adequacy of reinsurance coverage (e.g., Florida Program, Nationwide Excess) given the volatility of weather events.
- Health Segment Transition: Confirm the financial impact of the Group Health sale closing in July 2025 and the resulting change in the Allstate Health and Benefits segment composition.
- Investment Valuation: Assess the reversal of unrealized losses in the fixed income portfolio and the credit quality of the $54.4 billion fixed income holdings (92.3% investment grade).
- Reserve Adequacy: Monitor the $621 million favorable prior year reserve reestimates in the first six months of 2025 to ensure they do not indicate under-reserving in prior periods.